Upper gastrointestinal bleeding (UGIB) is a common medical emergency, with a reported
mortality of 2-10%. Patients identified as being at very low risk of either needing an …

Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and
direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in …

Description: This update of the 2010 International Consensus Recommendations on the
Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding (UGIB) refines …

This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy
(ESGE). It addresses the diagnosis and management of nonvariceal upper gastrointestinal …

Upper gastrointestinal bleeding is a common emergency presentation requiring prompt
resuscitation and management. Peptic ulcers are the most common cause of the condition …

Non-variceal upper gastrointestinal bleeding (NVUGIB) is bleeding that develops in the
oesophagus, stomach or proximal duodenum. Peptic ulcers, caused by Helicobacter pylori …

This is one of a series of statements discussing the use of GI endoscopy in common clinical
situations. The Standards of Practice Committee of the American Society for Gastrointestinal …

Diese interdisziplinäre Leitlinie unter Leitung der DGVS und Beteiligung benachbarter
Fachgesellschaften fasst die wichtigsten Aspekte zur Versorgung von Patienten mit …

Objective While it is recommended that patients presenting with acute upper gastrointestinal
bleeding (AUGIB) should receive endoscopic intervention within 24 hours, the optimal timing …

Background and Aims The American College of Gastroenterology recommends early risk
stratification in patients presenting with upper GI bleeding (UGIB). The AIMS65 score is a …